+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pompe Disease Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4848340
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
UP TO OFF
until Dec 31st 2019
1 of 3

FEATURED COMPANIES

  • Amicus Therapeutics
  • Audentes Therapeutics
  • BioMarin Pharmaceutical
  • EpiVax
  • Genzyme company
  • Oxyrane
  • MORE
The report on the global pompe disease treatment market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global pompe disease treatment market to grow with a CAGR of 9.0% over the forecast period from 2019-2025. The study on pompe disease treatment market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on pompe disease treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global pompe disease treatment market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global pompe disease treatment market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers
  • Growing prevalence of Pompe disease among population
2) Restraints
  • Expensive therapy treatments
3) Opportunities
  • Emerging immunotherapeutic approaches for Pompe Disease
Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global pompe disease treatment market is segmented on the basis of therapy type, molecule type, route of administration, and dosage forms.

The Global Pompe Disease Treatment Market by Therapy Type
  • Enzyme Replacement Therapy
  • Substrate Reduction Therapy
The Global Pompe Disease Treatment Market by Molecule Type
  • Biologics
  • Small Molecules
The Global Pompe Disease Treatment Market by Route Of Administration
  • Oral
  • Parenteral
The Global Pompe Disease Treatment Market by Dosage Forms
  • Solid
  • Liquid
Company Profiles

The companies covered in the report include
  • BioMarin Pharmaceutical
  • Amicus Therapeutics
  • Genzyme company
  • Oxyrane
  • Audentes Therapeutics
  • Sangamo BioSciences
  • EpiVax
  • Valerion Therapeutics
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the pompe disease treatment market.
2. Complete coverage of all the segments in the pompe disease treatment market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global pompe disease treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amicus Therapeutics
  • Audentes Therapeutics
  • BioMarin Pharmaceutical
  • EpiVax
  • Genzyme company
  • Oxyrane
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Pompe Disease Treatment Market Highlights
2.2. Pompe Disease Treatment Market Projection
2.3. Pompe Disease Treatment Market Regional Highlights

3. Global Pompe Disease Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Therapy Type
3.4.2. Growth Matrix Analysis by Molecule Type
3.4.3. Growth Matrix Analysis by Route of Administration
3.4.4. Growth Matrix Analysis by Dosage Forms
3.4.5. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Pompe Disease Treatment Market

4. Pompe Disease Treatment Market Macro Indicator Analysis

5. Global Pompe Disease Treatment Market by Therapy Type
5.1. Enzyme Replacement Therapy
5.2. Substrate Reduction Therapy

6. Global Pompe Disease Treatment Market by Molecule Type
6.1. Biologics
6.2. Small Molecules

7. Global Pompe Disease Treatment Market by Route of Administration
7.1. Oral
7.2. Parenteral

8. Global Pompe Disease Treatment Market by Dosage Forms
8.1. Solid
8.2. Liquid

9. Global Pompe Disease Treatment Market by Region 2019-2025
9.1. North America
9.1.1. North America Pompe Disease Treatment Market by Therapy Type
9.1.2. North America Pompe Disease Treatment Market by Molecule Type
9.1.3. North America Pompe Disease Treatment Market by Route of Administration
9.1.4. North America Pompe Disease Treatment Market by Dosage Forms
9.1.5. North America Pompe Disease Treatment Market by Country
9.2. Europe
9.2.1. Europe Pompe Disease Treatment Market by Therapy Type
9.2.2. Europe Pompe Disease Treatment Market by Molecule Type
9.2.3. Europe Pompe Disease Treatment Market by Route of Administration
9.2.4. Europe Pompe Disease Treatment Market by Dosage Forms
9.2.5. Europe Pompe Disease Treatment Market by Country
9.3. Asia-Pacific
9.3.1. Asia-Pacific Pompe Disease Treatment Market by Therapy Type
9.3.2. Asia-Pacific Pompe Disease Treatment Market by Molecule Type
9.3.3. Asia-Pacific Pompe Disease Treatment Market by Route of Administration
9.3.4. Asia-Pacific Pompe Disease Treatment Market by Dosage Forms
9.3.5. Asia-Pacific Pompe Disease Treatment Market by Country
9.4. RoW
9.4.1. RoW Pompe Disease Treatment Market by Therapy Type
9.4.2. RoW Pompe Disease Treatment Market by Molecule Type
9.4.3. RoW Pompe Disease Treatment Market by Route of Administration
9.4.4. RoW Pompe Disease Treatment Market by Dosage Forms
9.4.5. RoW Pompe Disease Treatment Market by Sub-region

10. Company Profiles and Competitive Landscape
10.1. Competitive Landscape in the Global Pompe Disease Treatment Market
10.2. Companies Profiled
10.2.1. BioMarin Pharmaceutical
10.2.2. Amicus Therapeutics
10.2.3. Genzyme company
10.2.4. Oxyrane
10.2.5. Audentes Therapeutics
10.2.6. Sangamo BioSciences
10.2.7. EpiVax
10.2.8. Valerion Therapeutics

11. Appendix
11.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • BioMarin Pharmaceutical
  • Amicus Therapeutics
  • Genzyme company
  • Oxyrane
  • Audentes Therapeutics
  • Sangamo BioSciences
  • EpiVax
  • Valerion Therapeutics
Note: Product cover images may vary from those shown
Adroll
adroll